{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T11:50:54Z","timestamp":1651492254072},"reference-count":14,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.transci.2013.05.004","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T07:15:38Z","timestamp":1371021338000},"page":"234-237","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Using Rheopheresis for stem cell Transplantation-Associated Thrombotic Microangiopathy (TA-TMA)"],"prefix":"10.1016","volume":"49","author":[{"given":"Marta","family":"Gonz\u00e1lez-Vicent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2013.05.004_b0005","doi-asserted-by":"crossref","first-page":"e2010033","DOI":"10.4084\/mjhid.2010.033","article-title":"Thrombotic microangiopathy in haematopoietic cell transplantation: an update","volume":"2","author":"Stavrou","year":"2010","journal-title":"Medit J Hemat Infect Dis"},{"key":"10.1016\/j.transci.2013.05.004_b0010","first-page":"495","article-title":"Thrombotic microangiopathy following bone marrow transplantation","volume":"14","author":"Pettitt","year":"1994","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2013.05.004_b0015","first-page":"247","article-title":"Bone marrow transplant-associated thrombotic microangiopathy: a case series","volume":"15","author":"Zeigler","year":"1995","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2013.05.004_b0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2013.05.004_b0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/sj.bmt.1703879","article-title":"Endothelial damage caused by cytomegalovirus and human herpesvirus-6","volume":"31","author":"Takatsuka","year":"2003","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2013.05.004_b0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2013.05.004_b0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2013.05.004_b0040","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"Von Willebarand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2013.05.004_b0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathic: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2013.05.004_b0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1526-0968.2001.00335.x","article-title":"Fibrinogen and adsorption in the diabetic foot syndrome and peripheral arterial occlusive disease: first clinical experience","volume":"5","author":"Richter","year":"2001","journal-title":"Therap Apher"},{"key":"10.1016\/j.transci.2013.05.004_b0055","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1526-0968.2003.00082.x","article-title":"Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial","volume":"7","author":"Klingel","year":"2003","journal-title":"Therap Apheresis Dial"},{"key":"10.1016\/j.transci.2013.05.004_b0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1525-1594.2002.06880.x","article-title":"RheoSorb: a specific adsorber for fibrinogen elimination in clinical situations with impaired rheology","author":"Koll","year":"2002","journal-title":"Artif Organs"},{"key":"10.1016\/j.transci.2013.05.004_b0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab","volume":"137","author":"Au","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2013.05.004_b0070","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transpl"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213001638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213001638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T10:29:11Z","timestamp":1539599351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050213001638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1473050213001638"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2013.05.004","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using Rheopheresis for stem cell Transplantation-Associated Thrombotic Microangiopathy (TA-TMA)","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2013.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}